Uridine and pyruvate protect T cells’ proliferative capacity from mitochondrial toxic antibiotics: a clinical pilot study
Open Access
- 18 June 2021
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-9
Abstract
Antibiotics that inhibit bacterial protein or nucleic acid synthesis and function can exert an off-target action on mitochondria (mitotoxic antibiotics), making actively dividing mammalian cells dependent on uridine and pyruvate supplementation. Based on this rationale, we carried out, for the first time, a randomized pilot study in 55 patients with asymptomatic bacteriuria or positive sperm culture, each treated with a single mitotoxic antibiotic with or without oral supplementation of uridine + pyruvate (Uripyr, Mitobiotix, Italy). The in vivo and ex vivo data show a a 3.4-fold higher value in the differential (before and after the antibiotic treatment) lymphocytes count and a 3.7-fold increase in the percentage of dividing T cells, respectively, in the Uripyr vs the control group. Our findings lay the groundwork to enhance the synergy between antibiotics and the immune system in order to optimize the administration protocols and widen the application potentials of antibiotic therapies as well as to re-evaluate old “forgotten” molecules to fight bacterial infections in the antibiotics resistance era.Keywords
This publication has 37 references indexed in Scilit:
- Mitochondria in innate immune responsesNature Reviews Immunology, 2011
- International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious DiseasesClinical Infectious Diseases, 2011
- Persistence of Uropathogenic Escherichia coli in the Face of Multiple AntibioticsAntimicrobial Agents and Chemotherapy, 2010
- Overview of the immune responseJournal of Allergy and Clinical Immunology, 2010
- EAU Guidelines for the Management of Urinary and Male Genital Tract Infections1European Urology, 2001
- Interference of Antibacterial Agents with Phagocyte Functions: Immunomodulation or "Immuno-Fairy Tales"?Clinical Microbiology Reviews, 2000
- Standardisation and quality assurance of lymphocyte proliferation assays for use in the assessment of immune functionJournal of Immunological Methods, 1999
- Antibiotics as biological response modifiersJournal of Antimicrobial Chemotherapy, 1990
- Human Cells Lacking mtDNA: Repopulation with Exogenous Mitochondria by ComplementationScience, 1989
- Effect of antibiotics on the immune responseThe American Journal of Medicine, 1982